Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (101)	10/5/1998 10:03:00 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 1475

Rick, Thanks for your feedback. I currently don't own the stock but I'm looking to add it to my holdings. From what I understand, it isn't a wound dressing but rather a process that allows transplantable tissue grafts from cadavers that are not subject to immune rejection. Lifecell's core technology is a propietary method of freeze-drying cells and biological tissues that precludes the damaging effects of ice crystals formation. They are also working in the area of extending preservation and long-term storage of platelets. They are working with M.D. Anderson Hospital on this project and the news release from last week seems to be encouraging. It is projected that this market is in the $400 million range. Your further input after any DD will be appreciated.